You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-493

Showing 1 - 25 of 384
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • ABT-493
  • +3 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

Completed
Has Results
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • ABT-493
  • +3 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Hepatitis C Trial in Worldwide (ABT-493, ABT-530)

Completed
Has Results
  • Hepatitis C
  • Dothan, Alabama
  • +41 more
Aug 31, 2020

Hepatitis C Virus Infection Trial in Ljubljana (glecaprevir, pibrentasvir)

Approved for marketing
  • Hepatitis C Virus Infection
  • Ljubljana, Slovenia
    Univ Medical Ctr Ljubljana /ID# 161419
Jan 14, 2020

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

Recruiting
  • Hepatitis C Virus (HCV)
  • Glecaprevir/Pibrentasvir (GLE/PIB)
  • Chandler, Arizona
  • +62 more
Aug 8, 2022

Hepatitis C Virus (HCV) Trial in China, Korea, Republic of (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Beijing, Beijing, China
  • +33 more
Nov 4, 2019

Hepatitis C Virus (HCV) Trial in China, Korea, Republic of, Singapore (Placebo, Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Beijing, Beijing, China
  • +47 more
Dec 5, 2019

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Hepatitis C Virus (HCV) Trial in Brazil (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • Vitoria, Espirito Santo, Brazil
  • +13 more
Mar 4, 2020

Insomnia, Traumatic Brain Injury Trial in Palo Alto (CBT-I, ABT-I)

Recruiting
  • Insomnia
  • Traumatic Brain Injury
  • CBT-I
  • ABT-I
  • Palo Alto, California
    VA Palo Alto Health Care System, Palo Alto, CA
Jan 6, 2023

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +123 more
Jun 15, 2022

Aveir DR Real-World Evidence Post-Approval Study

Not yet recruiting
  • Cardiac Pacemaker
  • +2 more
  • Aveir DR Leadless Pacemaker System
  • Sylmar, California
    Abbott
Jul 5, 2023

Aveir AR Coverage With Evidence Development (CED) Study

Not yet recruiting
  • Cardiac Pacemaker
  • +2 more
  • Aveir AR Leadless Pacemaker
  • Single-chamber atrial transvenous pacemaker
  • (no location specified)
Oct 30, 2023